Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma

Despite constant advances in the field of pediatric oncology, the survival rate of high-risk neuroblastoma patients remains poor. The molecular and genetic features of neuroblastoma, such as MYCN amplification and stemness status, have established themselves not only as potent prognostic and predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Macsek, Peter, Skoda, Jan, Krchniakova, Maria, Neradil, Jakub, Veselska, Renata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745636/
https://www.ncbi.nlm.nih.gov/pubmed/35008802
http://dx.doi.org/10.3390/ijms23010376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745636/
https://www.ncbi.nlm.nih.gov/pubmed/35008802
http://dx.doi.org/10.3390/ijms23010376

Ejemplares similares